Advertisements



We are Sorry, This Page doesn't Exist


Shekhar Gupta: Judge thyself too, Your Lordships

The judiciary is under threat from within - from stretching jurisdictions, headline-hunting and its inability to put its own house in order.....»»

Category: topSource: business-standardApr 20th, 2018

Shekhar Gupta: When spies plot peace

Some untold or barely told stories of Indian and Pakistani spymasters making peace on the sidelines of war.....»»

Category: topSource: business-standardMay 25th, 2018

Shekhar Gupta: Because Modiji says so

He's our most polarising leader, deeply hated by many but equally loved by more, especially the young. To extrapolate BJP's struggles in Gujarat and Karnataka to 2019 is being fatally complacent.....»»

Category: topSource: business-standardMay 18th, 2018

Shekhar Gupta: Return of the BJP"s "Iron Men"

Come to Ballari to see the BJP's starkest compromise with organised political crime and corruption yet because of its desperation to win Karnataka.....»»

Category: topSource: business-standardMay 11th, 2018

Shekhar Gupta: Dressing up military history in fatigues

Over the decades, a spiced up, hyper-nationalist version of military history has been built: That politicians wronged the generals. No wonder PM Modi got his facts all mixed up.....»»

Category: topSource: business-standardMay 4th, 2018

Shekhar Gupta: Because freedom can"t be salami-sliced

The media can disagree, fight and judge itself. But it can survive and thrive only by closing ranks when its freedoms are under attack.....»»

Category: topSource: business-standardApr 13th, 2018

Shekhar Gupta: Cracks in the Hindu consensus

BJP overpowered caste divisions to sweep 2014. But the Dalits are angry and the divides are back in play, spelling trouble for the party in 2019.....»»

Category: topSource: business-standardApr 6th, 2018

Five Prime initiates patient dosing in dose exploration cohort of Phase 1 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall3 hr. 20 min. ago

The Daily Biotech Pulse: Enzo"s Q4 Loss, Sanofi"s Positive Trial Results, ImmunoCellular To Delist

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting 52-week highs on Oct. 15) read more.....»»

Category: blogSource: benzinga3 hr. 20 min. ago

The Daily Biotech Pulse: Enzo"s Q4 Loss, Sanofi"s Positive Trial Results, ImmunoCellular To Delist

Here'.....»»

Category: earningsSource: benzinga3 hr. 35 min. ago

ResTORbio announces additional data from RTB101 Phase 2b clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall4 hr. 35 min. ago

LogicBio IPO: Undervalued, But Phase 1/2 Clinical Trial Will Commence By The End Of 2019

LogicBio IPO: Undervalued, But Phase 1/2 Clinical Trial Will Commence By The End Of 2019.....»»

Category: topSource: seekingalpha12 hr. 51 min. ago

Avita Medical announces Recell trial results presentation

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall17 hr. 20 min. ago

Aevi Genomics Medicine completes enrollment in part B of Phase 2 ASCEND trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 15th, 2018

Krystal Biotech announces interim results from Phase 1/2 trial of KB103

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 15th, 2018

OncoSec initiates Phase 2 cllinical trial of Tavo with Merck"s Keytruda

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 15th, 2018

Cellect Biotechnology reports safety data from Phase I/II trial of ApoGraft

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 15th, 2018

Dynavax"s SD-101 combined with Merck"s Keytruda selected in breast cancer trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 15th, 2018

Oil Jumps After Saudi Official Floats "Trial Balloon" Op-Ed Envisioning "Oil Weapon" Devastation

Oil Jumps After Saudi Official Floats "Trial Balloon" Op-Ed Envisioning "Oil Weapon" Devastation.....»»

Category: blogSource: zerohedgeOct 14th, 2018

The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results And IPOs

Here are a few catalysts that can dictate the directional moves of biotech stocks in the upcoming week: read more.....»»

Category: blogSource: benzingaOct 14th, 2018